Business Wire

InterVene, Inc. Announces $13 Million Series A Financing to Advance Recana™ System Through US Market Clearance

REDWOOD CITY, Calif.--(BUSINESS WIRE)--InterVene, Inc., a clinical-stage medical device company dedicated to developing interventional solutions for chronic venous insufficiency (CVI), announced today ...
Hosted on MSN

InterVene’s thrombectomy catheter success in first-in-human case

The first patient has been treated with InterVene’s Recana thrombectomy system for restoring patency (blood flow) in chronically obstructed deep veins and venous stents. The US-based clinical stage ...
eSchool News

Intervene K-12 Receives $150,000 Grant From National Nonprofit Accelerate To Make High-Impact Tutoring Sustainable And Cost-Effective

WASHINGTON, D.C.— Intervene K-12, a Houston-based online tutoring platform, announced today it will receive a $150,000 Innovation grant from Accelerate, a national nonprofit working to make ...
Business Wire

InterVene’s BlueLeaf Endovenous Valve Formation (EVF) System Granted Breakthrough Device Designation by the FDA

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--InterVene Inc. announced today that it has received Breakthrough Device Designation by the FDA for the company’s BlueLeaf ® Endovenous Valve Formation ...
eSchool News

Houston Business Journal Honors Intervene K-12 CEO as One of “Most Admired” CEOs in Houston

HOUSTON — Intervene K-12, a Houston-based online tutoring platform, is proud to announce that CEO and founder Aaron McCloud was recently named one of Houston’s “Most Admired” CEOs by the Houston ...